Cargando…
Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists
Intravenous magnesium sulphate allows safer intravenous β(2)-agonist delivery in acute-severe and life-threatening asthma attacks https://bit.ly/3veUpfC
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584576/ https://www.ncbi.nlm.nih.gov/pubmed/36338248 http://dx.doi.org/10.1183/20734735.0015-2022 |
| _version_ | 1784813298696323072 |
|---|---|
| author | Sellers, William F.S. James, Michael F.M. |
| author_facet | Sellers, William F.S. James, Michael F.M. |
| author_sort | Sellers, William F.S. |
| collection | PubMed |
| description | Intravenous magnesium sulphate allows safer intravenous β(2)-agonist delivery in acute-severe and life-threatening asthma attacks https://bit.ly/3veUpfC |
| format | Online Article Text |
| id | pubmed-9584576 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95845762022-11-04 Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists Sellers, William F.S. James, Michael F.M. Breathe (Sheff) Correspondence Intravenous magnesium sulphate allows safer intravenous β(2)-agonist delivery in acute-severe and life-threatening asthma attacks https://bit.ly/3veUpfC European Respiratory Society 2022-03 2022-04-05 /pmc/articles/PMC9584576/ /pubmed/36338248 http://dx.doi.org/10.1183/20734735.0015-2022 Text en Copyright ©ERS 2022 https://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Correspondence Sellers, William F.S. James, Michael F.M. Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists |
| title | Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists |
| title_full | Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists |
| title_fullStr | Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists |
| title_full_unstemmed | Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists |
| title_short | Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists |
| title_sort | magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584576/ https://www.ncbi.nlm.nih.gov/pubmed/36338248 http://dx.doi.org/10.1183/20734735.0015-2022 |
| work_keys_str_mv | AT sellerswilliamfs magnesiumsulphateintravenouslyreducestachycardiasideeffectsofb2agonists AT jamesmichaelfm magnesiumsulphateintravenouslyreducestachycardiasideeffectsofb2agonists |